Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DEXCOM INC Director's Dealing 2010

Mar 16, 2010

30198_dirs_2010-03-16_4464a2bb-3348-44b5-acf3-23ad1f07d6df.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2010-03-12

Reporting Person: Pacelli Steven Robert (CAO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-03-12 Incentive Stock Option (right to buy) $9.8 A 8927 Acquired 2020-03-12 Common Stock (8927) Direct
2010-03-12 Non-Qualified Stock Option (right to buy) $9.8 A 73073 Acquired 2020-03-12 Common Stock (73073) Direct

Footnotes

F1: The option vests and becomes exercisable as to 1/36th each month beginning one month following the date of grant and becomes fully vested on the third anniversary of the date of grant.

F2: Not applicable